Zobrazeno 1 - 7
of 7
pro vyhledávání: '"NA Kupryshina"'
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 13, Iss 1, Pp 50-57 (2019)
Aim. To assess hematopoiesis in follicular lymphoma (FL) patients at different disease stages with different morphologic structures of tumor and bone marrow microenvironment. Materials & Methods. The trial included 152 FL patients treated from 2006 t
Autor:
A. V. Mozhenkova, NA Kupryshina, E N Sorokin, NN Tupitsyn, EA Osmanov, NV Kokosadze, Gayane Tumyan, OM Volodina, VA Doronin, MA Frenkel, N. A. Falaleeva
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 10, Iss 2, Pp 176-181 (2017)
It is the first description of a case of follicular lymphoma with a loss of CD20 antigen expression during the anti-tumor treatment including rituximab in the NN Blokhin Russian Cancer Research Center. The article discusses the tactics of further man
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 9, Iss 2, Pp 208-207 (2016)
Aim. To investigate clinical and laboratory features of NK-cell lymphoblastic leukemia/lymphoma (NK-LL). Methods. Of 161 patients treated in the Department of Chemotherapy of Hemoblastoses of the N.N. Blokhin Russian Cancer Research Center from 2000
Autor:
Gorodetskiy VR; Department of Intensive Methods of Therapy, V.A. Nasonova Research Institute of Rheumatology, Kashirskoye shosse 34A, Moscow, 115522, Russia. gorodetskiyblood@mail.ru., Sidorova YV; Laboratory of Molecular Hematology, National Research Center for Hematology, Moscow, Russia., Kupryshina NA; Hematopoiesis Immunology Laboratory, N.N. Blokhin Russian Cancer Research Center, Moscow, Russia., Vasilyev VI; Diagnostic center of the MEDSI Clinic, Moscow, Russia., Probatova NA; Department of Pathology, N.N. Blokhin Russian Cancer Research Center, Moscow, Russia., Ryzhikova NV; Laboratory of Molecular Hematology, National Research Center for Hematology, Moscow, Russia., Sudarikov AB; Laboratory of Molecular Hematology, National Research Center for Hematology, Moscow, Russia.
Publikováno v:
Rheumatology international [Rheumatol Int] 2021 Jan; Vol. 41 (1), pp. 147-156. Date of Electronic Publication: 2020 Dec 05.
Autor:
Gorodetskiy VR; Department of Intensive Methods of Therapy, V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia., Probatova NA; Department of Pathology, N.N. Blokhin Russian Cancer Research Center, Moscow, Russia., Kupryshina NA; Hematopoiesis Immunology Laboratory, N.N. Blokhin Russian Cancer Research Center, Moscow, Russia., Palshina SG; Department of Intensive Methods of Therapy, V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia., Obukhova TN; Cytogenetic Laboratory, National Research Center for Hematology, Moscow, Russia., Sidorova YV; Laboratory of Molecular Hematology, National Research Center for Hematology, Moscow, Russia., Ryzhikova NV; Laboratory of Molecular Hematology, National Research Center for Hematology, Moscow, Russia., Sudarikov AB; Laboratory of Molecular Hematology, National Research Center for Hematology, Moscow, Russia.
Publikováno v:
Cancer management and research [Cancer Manag Res] 2020 Sep 30; Vol. 12, pp. 9449-9457. Date of Electronic Publication: 2020 Sep 30 (Print Publication: 2020).
Publikováno v:
Klinicheskaia laboratornaia diagnostika [Klin Lab Diagn] 2007 Nov (11), pp. 44-7.
Autor:
Votiakova OM, Osmanov DSh, Demina EA, Falaleeva NA, Bialik TE, Riabukhina IuE, Timofeeva OL, Gromova EG, Kupryshina NA, Kochergina NV
Publikováno v:
Terapevticheskii arkhiv [Ter Arkh] 2007; Vol. 79 (7), pp. 70-3.